Latest Breaking News On - Obecabtagene autoleucel - Page 1 : vimarsana.com

Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clonoSEQ® To Be Presented at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

More than 20 abstracts will be presented from clinical trials and real-world evidence using clonoSEQ for MRD assessment across multiple types of blood cancersSEATTLE, May 31, 2024 Adaptive.

United statesUniversity of chicagoCiltacabtagene autoleucelSusan bobulskyLisocabtagene maraleucelObecabtagene autoleucelBrexucabtagene autoleucel brexuKarina calzadillaErica jonesIdecabtagene vicleucel ideVendexv pomalidomideExchange commissionAmerican society of clinical oncologyAcalabrutinib and obinutuzumabAdaptive biotechnologies corporation nasdaqEuropean hematology association

Adaptive Biotechnologies Announces Data Supporting the

Adaptive Biotechnologies Announces Data Supporting the
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

University of chicagoUnited statesIdecabtagene vicleucel ideErica jonesSusan bobulskyVendexv pomalidomideObecabtagene autoleucelBrexucabtagene autoleucel brexuLisocabtagene maraleucelKarina calzadillaCiltacabtagene autoleucelAcalabrutinib and obinutuzumabCancer center clinica universidad de navarraExchange commissionAmerican society of clinical oncologyEuropean hematology association

Obecabtagene Autoleucel BLA for Relapsed/Refractory B-ALL Under FDA Review

The FDA has accepted for review the BLA for obecabtagene autoleucel's use in patients with relapsed or refractory B-cell acute lymphoblastic leukemia.

Cart cell therapyObecabtagene autoleucelB cell acute lymphoblastic leukemia

Obecabtagene Autoleucel (obe-cel, AUTO1) for Relapsed/Refractory Adult B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL): Pooled Analysis of the Ongoing FELIX Phase Ib/II Study

Claire Roddie, MD, PhD, presents data from the pooled analysis of the ongoing FELIX phase Ib/II study investigating obecabtagene autoleucel in patients with relapsed/refractory adult B-cell acute lymphoblastic leukemia.

San diegoUnited statesObecabtagene autoleucelClaire roddiePooled analysisClin oncolMedian dorFelix studyObe celCart cell therapyCar tFelix trialFelix study dataRelapsed refractoryb allRelapsed refractoryb cell acute lymphoblastic leukemia

Autolus Therapeutics (AUTL) Presents Clinical Data Updates

Autolus Therapeutics (AUTL) Presents Clinical Data Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesSan diegoSan diego convention centerLydia leeObecabtagene autoleucelJulia wilsonSusana noonanClaire roddieLauren williamsDrug administrationConsultant haematologist senior clinical researchCancer instituteAmerican society of hematologySa noonan communicationsUniversity college london